Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.69 |
| ▸ | MAG | P20916 | 6/20 | 0.63 |
| ▸ | SELL | P14151 | 1/20 | 0.63 |
| ▸ | SELP | P16109 | 1/20 | 0.63 |
| ▸ | CD22 | P20273 | 6/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL804936 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL29412465 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL30001019 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL29405239 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL14362275 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL24628357 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL12454161 | 1.00 | SIGLEC7 (0.69) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL30185416 | 0.98 | SIGLEC7 (0.66) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL31700860 | 0.97 | SIGLEC7 (0.68) | SIGLEC7MAGSELLSELPCD22 | |
| SCHEMBL30970760 | 0.97 | SIGLEC7 (0.70) | SIGLEC7MAGSELLSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11872238-B2 | Nutritional composition for use to enhance attention and/or reduce impulsivity | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2024-01-16 | — | — | US | disclosed |
| US-20240000122-A1 | COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN A SUBJECT TO SUPPORT NIGHT SLEEP DURATION | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2024-01-04 | — | — | US | disclosed |
| US-20230218648-A1 | USE OF HUMAN MILK OLIGOSACCHARIDES IN NUTRITIONAL COMPOSITIONS FOR ENHANCING BONE DEVELOPMENT AND/OR BONE STRENGTH | NESTLE SA (CH) | 2023-07-13 | — | — | US | disclosed |
| US-11528928-B2 | Composition comprising Siallylactose for use in enhancing learning skills and memory function | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2022-12-20 | — | — | US | disclosed |
| US-20220225627-A1 | A NUTRITIONAL COMPOSITION FOR USE TO ENHANCE EXECUTIVE FUNCTION | NESTLE SA (CH) | 2022-07-21 | — | — | US | disclosed |
| US-20210205341-A1 | COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN INFANTS OR YOUNG CHILDREN TO PREVENT OR TREAT A HEALTH DISORDER BY INCREASING GLP-1 SECRETION | Société des Produits Nestlé S.A. (CH) | 2021-07-08 | — | — | US | disclosed |
| US-20210205340-A1 | COMPOSITIONS COMPRISING SIALYLATED OLIGOSACCHARIDES FOR USE IN INFANTS OR YOUNG CHILDREN TO PREVENT LATER IN LIFE OBESITY OR RELATED COMORBIDITIES AND PROMOTE A HEALTHY GROWTH | Société des Produits Nestlé S.A. (CH) | 2021-07-08 | — | — | US | disclosed |
| US-20200121702-A1 | A NUTRITIONAL COMPOSITION FOR USE TO ENHANCE ATTENTION AND/OR REDUCE IMPULSIVITY | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2020-04-23 | — | — | US | disclosed |
| US-20180064152-A1 | COMPOSITION COMPRISING SIALLYLLACTOSE FOR USE IN ENHANCING LEARNING SKILLS AND MEMORY FUNCTION | Société des Produits Nestlé S.A. (CH) | 2018-03-08 | — | — | US | disclosed |